Toxins 2011, 3(4), 345-355; doi:10.3390/toxins3040345

Re-Assembled Botulinum Neurotoxin Inhibits CNS Functions without Systemic Toxicity

1email, 1email, 2email, 2email, 3email, 3email, 1email, 1email, 4email and 1,* email
Received: 24 February 2011; in revised form: 18 March 2011 / Accepted: 23 March 2011 / Published: 24 March 2011
(This article belongs to the Special Issue Development of Botulinum Toxin Drugs)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The therapeutic potential of botulinum neurotoxin type A (BoNT/A) has recently been widely recognized. BoNT/A acts to silence synaptic transmission via specific proteolytic cleavage of an essential neuronal protein, SNAP25. The advantages of BoNT/A-mediated synaptic silencing include very long duration, high potency and localized action. However, there is a fear of possible side-effects of BoNT/A due to its diffusible nature which may lead to neuromuscular blockade away from the injection site. We recently developed a “protein-stapling” technology which allows re-assembly of BoNT/A from two separate fragments. This technology allowed, for the first time, safe production of this popular neuronal silencing agent. Here we evaluated the re-assembled toxin in several CNS assays and assessed its systemic effects in an animal model. Our results show that the re-assembled toxin is potent in inhibiting CNS function at 1 nM concentration but surprisingly does not exhibit systemic toxicity after intraperitoneal injection even at 200 ng/kg dose. This shows that the re-assembled toxin represents a uniquely safe tool for neuroscience research and future medical applications.
Keywords: botulinum neurotoxin; nervous system; protein engineering; synapse; SNAREs; BOTOX; BITOX
PDF Full-text Download PDF Full-Text [349 KB, uploaded 24 March 2011 16:53 CET]

Export to BibTeX |

MDPI and ACS Style

Ferrari, E.; Maywood, E.S.; Restani, L.; Caleo, M.; Pirazzini, M.; Rossetto, O.; Hastings, M.H.; Niranjan, D.; Schiavo, G.; Davletov, B. Re-Assembled Botulinum Neurotoxin Inhibits CNS Functions without Systemic Toxicity. Toxins 2011, 3, 345-355.

AMA Style

Ferrari E, Maywood ES, Restani L, Caleo M, Pirazzini M, Rossetto O, Hastings MH, Niranjan D, Schiavo G, Davletov B. Re-Assembled Botulinum Neurotoxin Inhibits CNS Functions without Systemic Toxicity. Toxins. 2011; 3(4):345-355.

Chicago/Turabian Style

Ferrari, Enrico; Maywood, Elizabeth S.; Restani, Laura; Caleo, Matteo; Pirazzini, Marco; Rossetto, Ornella; Hastings, Michael H.; Niranjan, Dhevahi; Schiavo, Giampietro; Davletov, Bazbek. 2011. "Re-Assembled Botulinum Neurotoxin Inhibits CNS Functions without Systemic Toxicity." Toxins 3, no. 4: 345-355.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert